In an effort to allow FDA to sample water, soil and environmental conditions on USDA-regulated concentrated animal feeding operations (CAFOs), New York Sen. Kirsten E. Gillibrand introduced a bill that would provide the FDA authority to conduct microbial sampling on CAFOs as necessary for a foodborne illness outbreak investigation, determine the outbreak’s root cause or address other public health needs.

A proposed rule issued by AMS would implement a recommendation from the Cherry Industry Administrative Board to decrease the assessment rate established for 2019-20 and subsequent fiscal years.

The proliferation of various forms of date labels is enough to cause consumers not to buy a product with a short “sell by” date, leaving it to be junked at the store—or tossed prematurely at home—when the product is still perfectly fine.

FDA has finalized guidance to help facilities determine their business size under the Preventive Controls for Human Food and Preventive Controls for Animal Food rules issued in response to the FSMA.

Issued by AMS, this final rule revises the size requirements prescribed under the federal marketing order for Irish potatoes grown in Colorado.

This rule reallocates the membership of the council under the AMS regulations regarding a national research and promotion program for mushrooms.

USDA's FSIS and FDA released a formal agreement to address the regulatory oversight of human food products derived from the cells of livestock and poultry, which describes the oversight roles and responsibilities for both agencies and how they will collaborate to regulate the development and entry of these products into commerce.

USDA and FDA held a joint public meeting on the use of cell culture technology and discussed the technology, its theory, application and issues.